1. Home
  2. NVCR
  3. NVCR News

Latest NovoCure Limited (NVCR) News on November 21, 2024

Novocure secures FDA approval for add-ons to brain cancer treatment wearable
NVCR

Medical Device Network

6 hours ago

Novocure secures FDA approval for add-ons to brain cancer treatment wearable

NVCR

MT Newswires

9 hours ago

NovoCure Gets FDA Nod for Updated Optune Gio Arrays

Novocure Data at 2024 SNO Annual Meeting Highlights Product Innovation and Real-World Evidence for Tumor Treating Fields (TTFields) Therapy in Glioblastoma
NVCR

Business Wire

11 hours ago

Novocure Data at 2024 SNO Annual Meeting Highlights Product Innovation and Real-World Evidence for Tumor Treating Fields (TTFields) Therapy in Glioblastoma

FDA Approves Novocure’s Innovative HFE Transducer Arrays for Use With Optune Gio® for Glioblastoma
NVCR

Business Wire

11 hours ago

FDA Approves Novocure’s Innovative HFE Transducer Arrays for Use With Optune Gio® for Glioblastoma

NovoCure’s Strong Q3 and Leadership Changes in 2024
NVCR

TipRanks

21 days ago

NovoCure’s Strong Q3 and Leadership Changes in 2024

NovoCure Ltd (NVCR) Q3 2024 Earnings Call Highlights: Strong Revenue Growth Amid Strategic ...
NVCR

GuruFocus.com

22 days ago

NovoCure Ltd (NVCR) Q3 2024 Earnings Call Highlights: Strong Revenue Growth Amid Strategic ...

NovoCure (NVCR) Q3 2024 Earnings Call Transcript
NVCR

Motley Fool

22 days ago

NovoCure (NVCR) Q3 2024 Earnings Call Transcript

NVCR

MT Newswires

22 days ago

NovoCure Names New Chief Financial Officer

NVCR

MT Newswires

22 days ago

NovoCure Q3 Loss Narrows, Net Revenue Increases

NovoCure (NVCR) Reports Q3 Loss, Tops Revenue Estimates
NVCR

Zacks

22 days ago

NovoCure (NVCR) Reports Q3 Loss, Tops Revenue Estimates

NVCR

Associated Press Finance

22 days ago

NovoCure: Q3 Earnings Snapshot

Novocure Appoints Christoph Brackmann as Chief Financial Officer
NVCR

Business Wire

22 days ago

Novocure Appoints Christoph Brackmann as Chief Financial Officer

Novocure Reports Third Quarter 2024 Financial Results
NVCR

Business Wire

23 days ago

Novocure Reports Third Quarter 2024 Financial Results

Novocure's Optune Lua Receives FDA Approval For Lung Cancer Treatment
NVCR

GuruFocus.com

a month ago

Novocure's Optune Lua Receives FDA Approval For Lung Cancer Treatment

NVCR

Medical Device Network

a month ago

NovoCure scoops FDA approval on wearable for metastatic cancer treatment

NovoCure scoops FDA approval on wearable for metastatic cancer treatment
NVCR

Clinical Trials Arena

a month ago

NovoCure scoops FDA approval on wearable for metastatic cancer treatment

Novocure Withdraws Massive Gain On FDA Approval. Why It Could Struggle To Gain Traction.
NVCR

Investor's Business Daily

a month ago

Novocure Withdraws Massive Gain On FDA Approval. Why It Could Struggle To Gain Traction.

NVCR

MT Newswires

a month ago

Sector Update: Health Care Stocks Rise Premarket Wednesday

NVCR

MT Newswires

a month ago

Sector Update: Health Care

Novocure wins FDA approval for electric field device in lung cancer
NVCR

BioPharma Dive

a month ago

Novocure wins FDA approval for electric field device in lung cancer

NVCR

MT Newswires

a month ago

Top Premarket Gainers

FDA Approves NovoCure's Portable Device Producing Tumor-Treating Electric Fields For Previously Treated Lung Cancer Patients
NVCR

Benzinga

a month ago

FDA Approves NovoCure's Portable Device Producing Tumor-Treating Electric Fields For Previously Treated Lung Cancer Patients

NVCR

MT Newswires

a month ago

HC Wainwright Upgrades NovoCure to Buy From Neutral, Adjusts Price Target to $30 From $24

NVCR

Investing.com

a month ago

Novocure shares soar 33% as FDA approves lung cancer treatment

NovoCure (NVCR) Surges 10.7%: Is This an Indication of Further Gains?
NVCR

Zacks

a month ago

NovoCure (NVCR) Surges 10.7%: Is This an Indication of Further Gains?

Novocure Shoots Skyward, Reversing Setbacks, After FDA Approves Lung Cancer Treatment
NVCR

Investor's Business Daily

a month ago

Novocure Shoots Skyward, Reversing Setbacks, After FDA Approves Lung Cancer Treatment

NVCR

MT Newswires

a month ago

NovoCure Says US FDA Approves Optune Lua to Treat Lung Cancer; Shares Jump After Hours

FDA Approves Novocure’s Optune Lua® for the Treatment of Metastatic Non-Small Cell Lung Cancer
NVCR

Business Wire

a month ago

FDA Approves Novocure’s Optune Lua® for the Treatment of Metastatic Non-Small Cell Lung Cancer

Novocure to Report Third Quarter 2024 Financial Results
NVCR

Business Wire

2 months ago

Novocure to Report Third Quarter 2024 Financial Results

Novocure to Present Real-World Data at ESMO 2024 Demonstrating Improved Survival Outcomes for Newly Diagnosed Glioblastoma Patients with Increased Use of Tumor Treating Fields (TTFields) Therapy
NVCR

Business Wire

2 months ago

Novocure to Present Real-World Data at ESMO 2024 Demonstrating Improved Survival Outcomes for Newly Diagnosed Glioblastoma Patients with Increased Use of Tumor Treating Fields (TTFields) Therapy

Why NovoCure Stock Dived by 13% This Week
NVCR

Motley Fool

2 months ago

Why NovoCure Stock Dived by 13% This Week

NVCR

MT Newswires

3 months ago

NovoCure CEO Asaf Danziger to Retire, CFO Ashley Cordova Named Successor

Novocure Announces Planned CEO Transition
NVCR

Business Wire

3 months ago

Novocure Announces Planned CEO Transition

Novocure to Participate in 2024 Wells Fargo Healthcare Conference
NVCR

Business Wire

3 months ago

Novocure to Participate in 2024 Wells Fargo Healthcare Conference

Wall Street Analysts Think NovoCure (NVCR) Could Surge 35.96%: Read This Before Placing a Bet
NVCR

Zacks

3 months ago

Wall Street Analysts Think NovoCure (NVCR) Could Surge 35.96%: Read This Before Placing a Bet

Novocure Highlights TTFields Therapy in Treatment of Non-Small Cell Lung Cancer at 2024 World Conference on Lung Cancer
NVCR

Business Wire

3 months ago

Novocure Highlights TTFields Therapy in Treatment of Non-Small Cell Lung Cancer at 2024 World Conference on Lung Cancer

Biotech stocks: Which drugmakers are worth a buy?
NVCR

Yahoo Finance Video

3 months ago

Biotech stocks: Which drugmakers are worth a buy?

Even after rising 8.9% this past week, NovoCure (NASDAQ:NVCR) shareholders are still down 86% over the past three years
NVCR

Simply Wall St.

4 months ago

Even after rising 8.9% this past week, NovoCure (NASDAQ:NVCR) shareholders are still down 86% over the past three years

New Strong Buy Stocks for August 1st
NVCR

Zacks

4 months ago

New Strong Buy Stocks for August 1st

Wall Street Analysts Believe NovoCure (NVCR) Could Rally 26.39%: Here's is How to Trade
NVCR

Zacks

4 months ago

Wall Street Analysts Believe NovoCure (NVCR) Could Rally 26.39%: Here's is How to Trade

NovoCure (NVCR) Q2 2024 Earnings Call Transcript
NVCR

Motley Fool

4 months ago

NovoCure (NVCR) Q2 2024 Earnings Call Transcript

NVCR

MT Newswires

4 months ago

NovoCure Q2 Loss Narrows, Net Revenue Increases

NovoCure (NVCR) Reports Q2 Loss, Tops Revenue Estimates
NVCR

Zacks

4 months ago

NovoCure (NVCR) Reports Q2 Loss, Tops Revenue Estimates

NVCR

Associated Press Finance

4 months ago

NovoCure: Q2 Earnings Snapshot

Novocure Reports Second Quarter 2024 Financial Results
NVCR

Business Wire

4 months ago

Novocure Reports Second Quarter 2024 Financial Results

Novocure to Report Second Quarter 2024 Financial Results
NVCR

Business Wire

5 months ago

Novocure to Report Second Quarter 2024 Financial Results

IMAGO AIOS Prime Clinches Red Dot Award for 2024, Expands US Footprint with New Boston Warehouse
NVCR

PR Newswire

5 months ago

IMAGO AIOS Prime Clinches Red Dot Award for 2024, Expands US Footprint with New Boston Warehouse

Seibu Ikebukuro Main Store Slated for Summer 2025 Grand Re-opening as a New Department Store
NVCR

Business Wire

5 months ago

Seibu Ikebukuro Main Store Slated for Summer 2025 Grand Re-opening as a New Department Store

New Zealand scraps plan to tax livestock burps, farts
NVCR

AFP

5 months ago

New Zealand scraps plan to tax livestock burps, farts

ECB’s Lagarde Sees Multi-Meeting Rate Holds A Possibility
NVCR

The Wall Street Journal

5 months ago

ECB’s Lagarde Sees Multi-Meeting Rate Holds A Possibility

NVCR

Business Wire

5 months ago

InnoCare Announces Clearance of Clinical Trial of TYK2 Inhibitor ICP-332 by U.S. FDA

UK Unemployment Rises in Sign Inflationary Pressures Cool
NVCR

Bloomberg

5 months ago

UK Unemployment Rises in Sign Inflationary Pressures Cool

Insider-Owned Growth Companies On The Chinese Exchange In June 2024
NVCR

Simply Wall St.

5 months ago

Insider-Owned Growth Companies On The Chinese Exchange In June 2024

Here's Why New Toyo International Holdings (SGX:N08) Has Caught The Eye Of Investors
NVCR

Simply Wall St.

5 months ago

Here's Why New Toyo International Holdings (SGX:N08) Has Caught The Eye Of Investors

FDA panel votes to recommend Eli Lilly's Alzheimer's drug
NVCR

Yahoo Finance Video

5 months ago

FDA panel votes to recommend Eli Lilly's Alzheimer's drug

NVCR

GlobeNewswire

5 months ago

Chu Vision Institute Unveils Comprehensive Guide to LASIK Recovery and Aftercare, Pioneering Patient Care in Minneapolis

California seeks company profits in Big Oil climate lawsuit
NVCR

Reuters

5 months ago

California seeks company profits in Big Oil climate lawsuit

NVCR

USA TODAY

5 months ago

S&P 500, Nasdaq post record closing highs; Fed meeting, CPI ahead

Ipsen’s Iqirvo® receives U.S. FDA accelerated approval as a first-in-class PPAR treatment for primary biliary cholangitis
NVCR

GlobeNewswire

5 months ago

Ipsen’s Iqirvo® receives U.S. FDA accelerated approval as a first-in-class PPAR treatment for primary biliary cholangitis

Dutch Bros Inc. Announces Launch of Secondary Public Offering of Class A Common Stock
NVCR

Business Wire

5 months ago

Dutch Bros Inc. Announces Launch of Secondary Public Offering of Class A Common Stock

Media Advisory: Federal Housing Finance Agency Director Sandra Thompson Visits Affordable Apartment Complex in Dallas
NVCR

Business Wire

5 months ago

Media Advisory: Federal Housing Finance Agency Director Sandra Thompson Visits Affordable Apartment Complex in Dallas

Global Polycaprolactone Market to Record Revenue Worth US$ 1535.5 Mn by 2034; Anticipated to Experience CAGR of 10.3% During 2024 – 2034; states TNR, The Niche Research
NVCR

GlobeNewswire

5 months ago

Global Polycaprolactone Market to Record Revenue Worth US$ 1535.5 Mn by 2034; Anticipated to Experience CAGR of 10.3% During 2024 – 2034; states TNR, The Niche Research

$6.6 Billion Digital X-ray Market, 2024-2029: Development of AI-based Digital X-Ray Systems Present Business Opportunities
NVCR

GlobeNewswire

5 months ago

$6.6 Billion Digital X-ray Market, 2024-2029: Development of AI-based Digital X-Ray Systems Present Business Opportunities

2 Reasons to Buy Rivian Stock (and 1 Big Reason to Sell)
NVCR

Motley Fool

5 months ago

2 Reasons to Buy Rivian Stock (and 1 Big Reason to Sell)

DFR Gold Inc. Announces Amendment of WUO Land Option and Insider Loans
NVCR

CNW Group

5 months ago

DFR Gold Inc. Announces Amendment of WUO Land Option and Insider Loans

Walmart Stock Climbs After Dow Jones Giant Receives Upgrade, Major Price Target Hike
NVCR

Investor's Business Daily

5 months ago

Walmart Stock Climbs After Dow Jones Giant Receives Upgrade, Major Price Target Hike

EPCOR and HAWSCo Enter Ownership Transfer Agreement
NVCR

CNW Group

5 months ago

EPCOR and HAWSCo Enter Ownership Transfer Agreement

Video on Demand (VoD) Market Report 2024-2034: Netflix, Amazon, Google and Hulu Dominate
NVCR

GlobeNewswire

5 months ago

Video on Demand (VoD) Market Report 2024-2034: Netflix, Amazon, Google and Hulu Dominate

Southwest Airlines stock pops on report of Elliott's $2B stake
NVCR

Yahoo Finance Video

5 months ago

Southwest Airlines stock pops on report of Elliott's $2B stake

NVCR

Business Wire

5 months ago

Form 8.3 - Virgin Money UK plc

NVCR

MT Newswires

6 months ago

Wedbush Adjusts Price Target on NovoCure to $24 From $21, Maintains Neutral Rating

METIS Phase 3 Clinical Trial Met Primary Endpoint Significantly Delaying Time to Intracranial Progression with Improved Quality of Life Deterioration-Free Survival
NVCR

Business Wire

6 months ago

METIS Phase 3 Clinical Trial Met Primary Endpoint Significantly Delaying Time to Intracranial Progression with Improved Quality of Life Deterioration-Free Survival

TIGER Study Reports New TTFields Therapy Survival Results for Newly Diagnosed Glioblastoma Patients in Germany
NVCR

Business Wire

6 months ago

TIGER Study Reports New TTFields Therapy Survival Results for Newly Diagnosed Glioblastoma Patients in Germany

NovoCure Limited (NASDAQ:NVCR) Q1 2024 Earnings Call Transcript
NVCR

Insider Monkey

7 months ago

NovoCure Limited (NASDAQ:NVCR) Q1 2024 Earnings Call Transcript

NovoCure (NVCR) Q1 2024 Earnings Call Transcript
NVCR

Motley Fool

7 months ago

NovoCure (NVCR) Q1 2024 Earnings Call Transcript

NVCR

MT Newswires

7 months ago

NovoCure Shares Steady After Reporting Narrower Q1 Loss, Higher Revenue

NovoCure Ltd (NVCR) Q1 2024 Earnings: Revenue Surpasses Estimates, Narrower Net Loss Reported
NVCR

GuruFocus.com

7 months ago

NovoCure Ltd (NVCR) Q1 2024 Earnings: Revenue Surpasses Estimates, Narrower Net Loss Reported

NovoCure (NVCR) Reports Q1 Loss, Tops Revenue Estimates
NVCR

Zacks

7 months ago

NovoCure (NVCR) Reports Q1 Loss, Tops Revenue Estimates

NVCR

Associated Press Finance

7 months ago

NovoCure: Q1 Earnings Snapshot

Novocure Secures New $400 Million Multi-Tranche Non-Dilutive Debt Financing from Pharmakon
NVCR

Business Wire

7 months ago

Novocure Secures New $400 Million Multi-Tranche Non-Dilutive Debt Financing from Pharmakon

Novocure Reports First Quarter 2024 Financial Results
NVCR

Business Wire

7 months ago

Novocure Reports First Quarter 2024 Financial Results

NovoCure (NVCR) Expected to Beat Earnings Estimates: Should You Buy?
NVCR

Zacks

7 months ago

NovoCure (NVCR) Expected to Beat Earnings Estimates: Should You Buy?

Results of Novocure’s METIS Phase 3 Clinical Trial for Patients with Brain Metastasis from Non-Small Cell Lung Cancer to be Presented as Late-Breaking Abstract at ASCO 2024
NVCR

Business Wire

7 months ago

Results of Novocure’s METIS Phase 3 Clinical Trial for Patients with Brain Metastasis from Non-Small Cell Lung Cancer to be Presented as Late-Breaking Abstract at ASCO 2024

Novocure Announces 20 Presentations On Tumor Treating Fields, Highlighting Preclinical Effects in Pancreatic Cancer and Immune Effects, at American Association for Cancer Research (AACR) Annual Meeting 2024
NVCR

Business Wire

8 months ago

Novocure Announces 20 Presentations On Tumor Treating Fields, Highlighting Preclinical Effects in Pancreatic Cancer and Immune Effects, at American Association for Cancer Research (AACR) Annual Meeting 2024

NovoCure (NVCR) Moves to Buy: Rationale Behind the Upgrade
NVCR

Zacks

8 months ago

NovoCure (NVCR) Moves to Buy: Rationale Behind the Upgrade

Novocure to Report First Quarter 2024 Financial Results
NVCR

Business Wire

8 months ago

Novocure to Report First Quarter 2024 Financial Results

Why NovoCure Stock Soared 18.3% This Week
NVCR

Motley Fool

8 months ago

Why NovoCure Stock Soared 18.3% This Week

Why Novocure Stock Is Jumping Today
NVCR

Motley Fool

8 months ago

Why Novocure Stock Is Jumping Today

NovoCure (NVCR) Soars 12.0%: Is Further Upside Left in the Stock?
NVCR

Zacks

8 months ago

NovoCure (NVCR) Soars 12.0%: Is Further Upside Left in the Stock?

Novocure Surges 12% On Brain Tumors Study; But Some Analysts Are Bearish
NVCR

Investor's Business Daily

8 months ago

Novocure Surges 12% On Brain Tumors Study; But Some Analysts Are Bearish

Novocure Surges And Flashes A Bullish Sign On Promising Results For Brain Cancer Treatment
NVCR

Investor's Business Daily

8 months ago

Novocure Surges And Flashes A Bullish Sign On Promising Results For Brain Cancer Treatment

NVCR

Reuters

8 months ago

UPDATE 1-Novocure's lung cancer therapy succeeds in late-stage trial

NVCR

Reuters

8 months ago

Novocure's device shown to slow cancer progression in the brain in trial

NVCR

Reuters

8 months ago

Novocure's lung cancer therapy succeeds in late-stage trial

METIS Phase 3 Clinical Trial Met Primary Endpoint, Demonstrating a Statistically Significant Extension in Time to Intracranial Progression for Patients with Brain Metastases from Non-Small Cell Lung Cancer
NVCR

Business Wire

8 months ago

METIS Phase 3 Clinical Trial Met Primary Endpoint, Demonstrating a Statistically Significant Extension in Time to Intracranial Progression for Patients with Brain Metastases from Non-Small Cell Lung Cancer

Does NovoCure (NVCR) Have the Potential to Rally 63.51% as Wall Street Analysts Expect?
NVCR

Zacks

8 months ago

Does NovoCure (NVCR) Have the Potential to Rally 63.51% as Wall Street Analysts Expect?

INNOVATE-3 Late Breaking Abstract Selected as a Best Oral Presentation at ESGO
NVCR

Business Wire

8 months ago

INNOVATE-3 Late Breaking Abstract Selected as a Best Oral Presentation at ESGO

Is NovoCure Limited (NASDAQ:NVCR) Worth US$16.0 Based On Its Intrinsic Value?
NVCR

Simply Wall St.

9 months ago

Is NovoCure Limited (NASDAQ:NVCR) Worth US$16.0 Based On Its Intrinsic Value?

NovoCure Limited (NASDAQ:NVCR) Q4 2023 Earnings Call Transcript
NVCR

Insider Monkey

9 months ago

NovoCure Limited (NASDAQ:NVCR) Q4 2023 Earnings Call Transcript

NovoCure (NVCR) Q4 2023 Earnings Call Transcript
NVCR

Motley Fool

9 months ago

NovoCure (NVCR) Q4 2023 Earnings Call Transcript

Share on Social Networks: